Rockeby European patent granted for CanDia5
Rockeby biomed Ltd announced that it has been granted an European Patent by the European Patent Office, with relation to CanDia5 candida assay patent.
The Patent (European Patent No. 1 381 864) relates to a method and a means of diagnosing Candida infection. In particular the present invention relates to a method of diagnosing Candida infection which is both sensitive and rapid. This further extends Rockeby’s patent coverage of its Candida diagnosis technology to the United Kingdom from countries (Australia, Japan and USA) that had previously granted patents.
Rockeby currently markets and distributes CanDia5® in Australia, New Zealand, Italy, Singapore and United Arab Emirates.
Most read news
Topics
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.